Bioarchitech Overview

  • Founded
  • 2014

Founded
  • Status
  • Private

  • Employees
  • 5

Employees
  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $1.2M

  • Investors
  • 2

Bioarchitech General Information

Description

Operator of a biotechnology company intended to improve cancer therapy. The company engineers antibodies and other proteins, encoding them within the genome of an oncolytic virus that releases potent immunotherapy molecules into the surrounding tumor microenvironment, enabling physicians to orchestrate the destruction of tumor cells by the patient's own immune system.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • BioEscalator, Innovation Building
  • University of Oxford, Old Road Campus, Roosevelt Drive, Headington
  • Oxford OX3 7FZ
  • England, United Kingdom
+44 01865 000000

Bioarchitech Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bioarchitech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Angel (individual) 01-Feb-2022 $1.2M 00.000 000.00 Completed Generating Revenue
6. Angel (individual) 05-May-2021 00.00 00.000 00.000 Completed Generating Revenue
5. Angel (individual) 03-Apr-2019 00000 00000 000 Completed Generating Revenue
4. Angel (individual) 20-Oct-2017 00000 00000 00.000 Completed Generating Revenue
3. Grant 01-Dec-2016 00000 00000 Completed Generating Revenue
2. Early Stage VC 17-Mar-2016 $70.9K $226K 00000 Completed Generating Revenue
1. Early Stage VC 13-Aug-2015 $155K $155K 00000 Completed Generating Revenue
To view Bioarchitech’s complete valuation and funding history, request access »

Bioarchitech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.00
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.00
Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 50,000 $0.001355 $1.36 $1.36 1x $1.36 3.79%
Ordinary 165,750 $0.001355 $0.81 $0.81 1x $0.81 12.57%
To view Bioarchitech’s complete cap table history, request access »

Bioarchitech Patents

Bioarchitech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201621665-D0 Chimeric oncolytic virus Inactive 20-Dec-2016
GB-201522317-D0 Chimeric oncolytic virus Inactive 17-Dec-2015

Bioarchitech Executive Team (4)

Name Title Board Seat Contact Info
Kevin Maskell Co-Founder & Research Director
Hannah Chen Co-Founder
Geoffrey Hale Ph.D Co-Founder, Managing Director & Board Member
You’re viewing 3 of 4 executive team members. Get the full list »

Bioarchitech Board Members (2)

Name Representing Role Since
Geoffrey Hale Ph.D Self Co-Founder, Managing Director & Board Member 000 0000
You’re viewing 1 of 2 board members. Get the full list »

Bioarchitech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bioarchitech Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Innovate UK Government 000 0000 000000 0
Oxford Technology Management Venture Capital Minority 000 0000 000000 0
To view Bioarchitech’s complete investors history, request access »